Patient Pathfinder: Clinical Trials
Clinical Trials for Prostate Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 819 active Prostate Cancer trials
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Study Type: Interventional Phase 3
Non-Invasive Biomarkers in Prostate Cancer Disease Management
Study Type: Observational
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
Study Type: Interventional Phase 2
Contributions to Hypertension With Androgen Deprivation Therapy
Study Type: Interventional Phase 4
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Study Type: Interventional Phase 1
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
Study Type: Interventional Phase 1
The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer
Study Type: Interventional Phase 2
A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.
Study Type: Interventional Phase 1
There are 819 active Prostate Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now